Amber, Kubat join NeHII
OMAHA, Neb. — Specialty pharmacy provider Amber Pharmacy and pharmacy retailer Kubat Pharmacy have joined the first network to electronically exchange clinical patient information and medication therapy with healthcare providers in and around Nebraska, the Nebraska Health Information Initiative said Wednesday.
NeHII — a nonprofit health information exchange designed to allow the sharing of clinical and administrative data between providers in Nebraska and surrounding states — said that as part of the exchange, the pharmacies would have secure access to customers’ most current and accurate medication history and information, allowing them to set new standards for safety and care.
“We are delighted to be the first pharmacy in the state of Nebraska to join the NeHII network,” Amber Pharmacy president Mike Agostino said. “Amber Pharmacy has been in the forefront of providing prescription services to the transplant community for almost 15 years.”
Salix granted three patents for Xifaxan
RALEIGH, N.C. — The U.S. Patent and Trademark Office has awarded Salix Pharmaceuticals three patents related to a drug used for travelers’ diarrhea.
Salix announced Wednesday that it had secured patents for the drug Xifaxan (rifaximin) covering its methods of treating travelers’ diarrhea, as well as two related to the drug’s chemical composition.
The patents are set to expire between 2024 and 2029.
Sagent to issue IPO
SCHAUMBURG, Ill. — Sagent Pharmaceuticals has increased the number of shares it’s issuing in its initial public offering on the Nasdaq, the drug maker said Wednesday.
Originally planning to offer 5 million shares, the company has increased that number to 5.75 million shares at $16 per share.
The underwriters have a 30-day option to purchase up to an additional 862,500 shares at the IPO price. The offering is expected to close next Tuesday.